Sisram Medical マネジメント
マネジメント 基準チェック /24
Sisram Medicalの CEO はLior Dayanで、 Jun2017年に任命され、 の在任期間は 7.42年です。 の年間総報酬は$ 1.53Mで、 56.6%給与と43.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.2%を直接所有しており、その価値はHK$ 3.34M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と7.3年です。
主要情報
Lior Dayan
最高経営責任者
US$1.5m
報酬総額
CEO給与比率 | 56.6% |
CEO在任期間 | 7.4yrs |
CEOの所有権 | 0.2% |
経営陣の平均在職期間 | 1.8yrs |
取締役会の平均在任期間 | 7.3yrs |
経営陣の近況
Recent updates
What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You
Oct 07Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Aug 23Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet
Jul 24Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Aug 01These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
May 19Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?
May 03If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late
Apr 11Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital
Mar 17Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?
Nov 22Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Aug 22Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital
Jul 27Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair
Jun 24CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$24m |
Mar 31 2024 | n/a | n/a | US$28m |
Dec 31 2023 | US$2m | US$863k | US$31m |
Sep 30 2023 | n/a | n/a | US$35m |
Jun 30 2023 | n/a | n/a | US$38m |
Mar 31 2023 | n/a | n/a | US$39m |
Dec 31 2022 | US$3m | US$1m | US$40m |
Sep 30 2022 | n/a | n/a | US$38m |
Jun 30 2022 | n/a | n/a | US$35m |
Mar 31 2022 | n/a | n/a | US$33m |
Dec 31 2021 | US$2m | US$767k | US$31m |
Sep 30 2021 | n/a | n/a | US$28m |
Jun 30 2021 | n/a | n/a | US$24m |
Mar 31 2021 | n/a | n/a | US$19m |
Dec 31 2020 | US$769k | US$596k | US$13m |
Sep 30 2020 | n/a | n/a | US$13m |
Jun 30 2020 | n/a | n/a | US$13m |
Mar 31 2020 | n/a | n/a | US$17m |
Dec 31 2019 | US$759k | US$606k | US$21m |
Sep 30 2019 | n/a | n/a | US$22m |
Jun 30 2019 | n/a | n/a | US$24m |
Mar 31 2019 | n/a | n/a | US$23m |
Dec 31 2018 | US$884k | US$560k | US$22m |
Sep 30 2018 | n/a | n/a | US$18m |
Jun 30 2018 | n/a | n/a | US$14m |
Mar 31 2018 | n/a | n/a | US$12m |
Dec 31 2017 | US$829k | US$361k | US$11m |
報酬と市場: Liorの 総報酬 ($USD 1.53M ) は、 Hong Kong市場 ($USD 359.96K ) の同規模の企業の平均を上回っています。
報酬と収益: Liorの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Lior Dayan (54 yo)
7.4yrs
在職期間
US$1,526,000
報酬
Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and its President since 2023 and is responsible for its overall and day-to-day manageme...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Executive Chairman | 8.6yrs | US$27.00k | 0.053% HK$ 890.0k | |
President | 7.4yrs | US$1.53m | 0.20% HK$ 3.3m | |
Chief Financial Officer | less than a year | データなし | データなし | |
Chief Operating Officer | 6.6yrs | データなし | データなし | |
VP of Finance | 1.8yrs | データなし | データなし | |
Chief Information Officer | less than a year | データなし | データなし | |
Chief Marketing Officer | 1.8yrs | データなし | データなし | |
Chief People Officer | 1.8yrs | データなし | データなし | |
President of ROW | 1.8yrs | データなし | データなし | |
EVP of R&D | 1.8yrs | データなし | データなし | |
President NA | 1.8yrs | データなし | データなし | |
Company Secretary | 2.8yrs | データなし | データなし |
1.8yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: 1696の経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Executive Chairman | 8.6yrs | US$27.00k | 0.053% HK$ 890.0k | |
President | 7.4yrs | US$1.53m | 0.20% HK$ 3.3m | |
Independent Non-Executive Director | 7.3yrs | US$32.00k | データなし | |
Non-Executive Director | 8.1yrs | データなし | データなし | |
Independent Non-Executive Director | 7.3yrs | US$32.00k | データなし | |
Independent Non-Executive Director | 7.3yrs | US$32.00k | データなし | |
Independent Non-Executive Director | 7.3yrs | US$32.00k | データなし | |
Non-Executive Director | 4.3yrs | データなし | データなし |
7.3yrs
平均在職期間
51.5yo
平均年齢
経験豊富なボード: 1696の 取締役会 は 経験豊富 であると考えられます ( 7.3年の平均在任期間)。